NeoGenomics, Inc. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
NeoGenomics, Inc. (NEO) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $5.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-04-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2016-04-18
- NeoGenomics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $0.00.
- NeoGenomics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $0.00.
- NeoGenomics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $5.00M, a 0.00% change from fiscal 2014.
- NeoGenomics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $5.00M, a 0.00% change from fiscal 2013.
- NeoGenomics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2013 was $5.00M, a 0.00% change from fiscal 2012.
- NeoGenomics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2012 was $5.00M.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2015-12-31 | $5.00M 10-K · filed 2016-04-18 | |||
| 2014-12-31 | $5.00M 10-K · filed 2015-03-03 | |||
| 2013-12-31 | $5.00M 10-K · filed 2014-02-24 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $0.00 derived: sum of 2 quarters · filed 2013-02-21 | $5.00M 10-K · filed 2013-02-21 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-05 | $5.00M 10-Q · filed 2012-11-05 | ||
| 2012-06-30 | $5.00M 10-Q/A · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |